<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20141012019511N4</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-07-12</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Mindfulness-Based Cognitive Therapy for the Treatment of primary Chronic Headache Pain</public_title>
      <acronym></acronym>
      <scientific_title>An Empirical Examination of the Mindfulness‐Based Cognitive Therapy on cognitive adjustment and  management of  chronic pain in the patient with primary Headache Pain</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2017-12-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>70</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/30736</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Method of randomization was the Simple randomization assignment. The Unit of randomization was individual. Random sequence was created via a web-based random number sequencer (http://www.randomizer.org). in order to Hide the random allocation, the individual involved in the implementation of the randomization process was separated from other researchers in order to reduce the probable bias.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Primary Headache Pain.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The MBCT for pain approach incorporates one of the strengths of CBT protocols in that cognitive exercises are included that train the mind to be more aware, more often, of cognitions, emotions, behaviors, and pain, and the links between them. Unlike in CBT however, the CBT‐orientedexercises in the MBCT protocol are not aimed toward changing any of these aspects of the moment‐to‐moment experience. Rather they are geared toward simply heightening awareness, thereby providing an entry point to stepping out of automatic pilot and doing mode, and into being mode. In The MBCT protocol, the first half of treatment is focused on enhancing awareness of our habitual patterns, and this awareness is built upon in the second half of treatment to enhance skillful, wise responding (i.e., choosing to intentionally respond rather than react—this is what is meant by “skillful” here).The main modules of MBCT for chronic pain Include session 1; Stepping Out of Automatic Pain Habits, session 2; Facing the Challenge. session 3; The Breath as an Anchor, session 4; Learning to Stay Present, session 5; Active Acceptance, session 6; Seeing Thoughts as Just Thoughts, session 7; Taking Care of Myself, session 8; Harnessing the Power of the Mind for Chronic Pain Management. Intervention 2: Control group: Attention Placebo Control group  (APC): Control group that serves as a baseline for comparison for assessment of the effects of the particular intervention. While persons in the treatment group receive the experimental treatment being studied, the attention placebo control group receives a treatment that mimics the amount of time and attention received by the treatment group but is thought not to have a specific effect upon the subjects.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
The only part of the data, such as information on the main outcome, that in the present study, is the severity of pain and Some of the secondary outcomes (Depression) variable will be shared.

When:
Starting the access period from 1399

To whom:
Data will only be available to researchers in academia and universities.

Conditions:
The application of the present study documents is permitted in the development of clinical research and referral in the compilations.

Where to obtain:
Dr Sarah  Namjoo, No 12, Moazzen Blvd, Rajaee Shahr, Karaj, Alborz. Postal code: namjoopsy@gmail.com

How to obtain:
The applicant for research information can receive a documentation of study at the end of 2018-2019 by email to Dr. Sarah  Namjoo.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Farhad Assarehzadegan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Beheshti University of Medical Sciences,  Daneshjoo Blvd, shahid shahriari Floor, Yaman Ave., Shahid Chamran., Tehran Town</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985717443</zip>
        <telephone>+98 23871</telephone>
        <email>fassarzadegan@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>sarah Namjoo</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Islamic Azad University of Alborz, Moazen Boulevared, Rajai Street, Karaj, Alborz</address>
        <city>Alborz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1411713135</zip>
        <telephone>+98 26 3418 2580</telephone>
        <email>namjoopsy@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>At least 19 years of age
At least 3 pain days per month (for the past 3 month) due to a primary headache pain type
headache pain was the primary source of pain
if currently using psychotropic or headache medications, use of these medications must have begun at least 4 weeks before baseline assessment
reading ability was sufficient to comprehend self-monitoring forms</inclusion_criteria>
      <agemin>19 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>human immunodeficiency virus-related pain and cancer pain because these are associated with malignant disease
history of seizure or facial neuralgia, as these conditions might preclude the accurate diagnosis of headache
significant cognitive impairment</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The MBCT for pain approach incorporates one of the strengths of CBT protocols in that cognitive exercises are included that train the mind to be more aware, more often, of cognitions, emotions, behaviors, and pain, and the links between them. Unlike in CBT however, the CBT‐orientedexercises in the MBCT protocol are not aimed toward changing any of these aspects of the moment‐to‐moment experience. Rather they are geared toward simply heightening awareness, thereby providing an entry point to stepping out of automatic pilot and doing mode, and into being mode. In The MBCT protocol, the first half of treatment is focused on enhancing awareness of our habitual patterns, and this awareness is built upon in the second half of treatment to enhance skillful, wise responding (i.e., choosing to intentionally respond rather than react—this is what is meant by “skillful” here).The main modules of MBCT for chronic pain Include session 1; Stepping Out of Automatic Pain Habits, session 2; Facing the Challenge. session 3; The Breath as an Anchor, session 4; Learning to Stay Present, session 5; Active Acceptance, session 6; Seeing Thoughts as Just Thoughts, session 7; Taking Care of Myself, session 8; Harnessing the Power of the Mind for Chronic Pain Management.</i_keyword>
      <i_keyword>Control group: Attention Placebo Control group  (APC): Control group that serves as a baseline for comparison for assessment of the effects of the particular intervention. While persons in the treatment group receive the experimental treatment being studied, the attention placebo control group receives a treatment that mimics the amount of time and attention received by the treatment group but is thought not to have a specific effect upon the subjects.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain interference. Timepoint: From baseline until 6 months. Method of measurement: The Brief Pain Inventory (BPI).</prim_outcome>
      <prim_outcome>Pain-Related Cognitive Processes. Timepoint: From baseline until 6 months. Method of measurement: Pain-Related Cognitive Processes Questionnaire.</prim_outcome>
      <prim_outcome>Pain intensity. Timepoint: From baseline until 6 months. Method of measurement: Numerical Rating Scale (NRS).</prim_outcome>
      <prim_outcome>Pain intensity. Timepoint: From baseline until 6 months. Method of measurement: The Brief Pain Inventory (BPI).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Mindfulness. Timepoint: From baseline until 6 months. Method of measurement: Mindful Attention Awareness Scale (MAAS).</sec_outcome>
      <sec_outcome>Negative Emotions and Affects. Timepoint: From baseline until 6 months. Method of measurement: Depression Anxiety and Stress Scales (DASS-21).</sec_outcome>
      <sec_outcome>Cognitive flexibility. Timepoint: Before the intervention. Method of measurement: Cognitive Flexibility Inventory (CFI).</sec_outcome>
      <sec_outcome>Alexithymia. Timepoint: Before the intervention. Method of measurement: Toronto Alexithymia Scale.</sec_outcome>
      <sec_outcome>Pain Self Efficacy. Timepoint: From baseline until 6 months. Method of measurement: Pain Self Efficacy Questionnaire (PSEQ).</sec_outcome>
      <sec_outcome>Pain Acceptance. Timepoint: From baseline until 6 months. Method of measurement: Chronic Pain Acceptance Questionnaire (CPAQ).</sec_outcome>
      <sec_outcome>Pain Catastrophizing. Timepoint: From baseline until 6 months. Method of measurement: Pain Catastrophizing Scale (PCS).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2018-04-18</approval_date>
        <contact_name>Ethics committee of Alborz Islamic Azad University of Medical Sciences</contact_name>
        <contact_address>Islamic Azad University of Alborz, Moazen Boulevared, Rajai Street, Karaj, Alborz Karaj Alborz Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
